This is a preview of subscription content, log in via an institution to check access.
Reference
Diez-Madueno K, et al. Severe pancytopenia as a rare adverse event related to adalimumab biosimilar. Piel 37: 273-276, No. 5, May 2022. Available from: URL: http://doi.org/10.1016/j.piel.2021.03.013 [Spanish; summarised from a translation]
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1917, 25 (2022). https://doi.org/10.1007/s40278-022-19896-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19896-0